Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Alkermes (ALKS) has a market cap of $4.61 billion USD. According to our data, Alkermes is ranked No.2675 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $4.61 B |
-1.52%
|
| Dec 31, 2024 | $4.68 B |
3.68%
|
| Dec 29, 2023 | $4.51 B |
6.16%
|
| Dec 30, 2022 | $4.25 B |
12.34%
|
| Dec 31, 2021 | $3.78 B |
16.59%
|
| Dec 31, 2020 | $3.24 B |
-2.21%
|
| Dec 31, 2019 | $3.32 B |
-30.87%
|
| Dec 31, 2018 | $4.80 B |
-46.08%
|
| Dec 29, 2017 | $8.90 B |
-1.53%
|
| Dec 30, 2016 | $9.04 B |
-29.98%
|
| Dec 31, 2015 | $12.91 B |
35.55%
|
| Dec 31, 2014 | $9.52 B |
44.02%
|
| Dec 31, 2013 | $6.61 B |
119.55%
|
| Dec 31, 2012 | $3.01 B |
6.68%
|
| Dec 30, 2011 | $2.82 B |
41.37%
|
| Dec 31, 2010 | $2.00 B |
30.50%
|
| Dec 31, 2009 | $1.53 B |
-11.64%
|
| Dec 31, 2008 | $1.73 B |
-31.69%
|
| Dec 31, 2007 | $2.54 B |
16.60%
|
| Dec 29, 2006 | $2.17 B |
-30.07%
|
| Dec 30, 2005 | $3.11 B |
35.70%
|
| Dec 31, 2004 | $2.29 B |
4.37%
|
| Dec 31, 2003 | $2.20 B |
115.31%
|
| Dec 31, 2002 | $1.02 B |
-76.21%
|
| Dec 31, 2001 | $4.29 B |
-15.98%
|
| Dec 29, 2000 | $5.10 B |
27.74%
|
| Dec 31, 1999 | $3.99 B |
121.41%
|
| Dec 31, 1998 | $1.80 B |
11.64%
|
| Dec 31, 1997 | $1.62 B |
-14.52%
|
| Dec 31, 1996 | $1.89 B |
192.91%
|
| Dec 29, 1995 | $0.65 B |
273.53%
|
| Dec 30, 1994 | $0.17 B |
-69.64%
|
| Dec 31, 1993 | $0.57 B |
-17.65%
|
| Dec 31, 1992 | $0.69 B |
-52.78%
|
| Dec 31, 1991 | $1.46 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Teva Pharmaceutical Industries
TEVA
|
$15.60 B |
0.000 M
|
Israel
|
| Market Cap | = | ALKS Stock Price | * | ALKS Shares Outstanding |
| = | $27.94 | * | 0.16 B | |
| = | $4.61 B |